ALDH9A1 Antibodies

Santa Cruz Biotechnology features a diverse variety of ALDH9A1 monoclonal antibodies for research focused on understanding ALDH9A1 protein functions. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ALDH9A1, or aldehyde dehydrogenase 9 family member A1, is an essential enzyme that metabolizes aldehydes and contributes to cellular detoxification processes. ALDH9A1 maintains cellular redox balance and has been linked to various health conditions, including neurodegenerative diseases and cancer. Research has shown ALDH9A1's significance in multiple cellular pathways and metabolic processes. Understanding ALDH9A1's biological functions can reveal new therapeutic approaches for various diseases. Ongoing studies continue to uncover novel roles of ALDH9A1 in health and disease. Extensive validation ensures reliable detection and characterization of ALDH9A1 across multiple experimental approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of ALDH9A1 and its potential therapeutic applications.